Published in Curr Med Res Opin on December 01, 2004
Risk of depression in women with psoriasis: a cohort study. Br J Dermatol (2015) 1.45
The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients. Arch Dermatol Res (2006) 1.03
The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. J Invest Dermatol (2013) 0.89
Economic and comorbidity burden among moderate-to-severe psoriasis patients with comorbid psoriatic arthritis. Arthritis Care Res (Hoboken) (2015) 0.78
Influence of psoriasis on circulatory system function assessed in echocardiography. Arch Dermatol Res (2015) 0.75
Richness of human gut microbiome correlates with metabolic markers. Nature (2013) 6.93
Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med (2012) 6.17
A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med (2007) 5.39
A randomized trial of epidural glucocorticoid injections for spinal stenosis. N Engl J Med (2014) 5.01
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet (2006) 4.26
Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health (2013) 2.82
Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial. JAMA (2003) 2.50
Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study. J Am Acad Dermatol (2006) 1.58
Burden of illness in Parkinson's disease. Mov Disord (2005) 1.48
Economic outcome of cardiac CT-based evaluation and standard of care for suspected acute coronary syndrome in the emergency department: a decision analytic model. Acad Radiol (2011) 1.45
Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report--Part II. Value Health (2009) 1.43
Relapse, rebound, and psoriasis adverse events: an advisory group report. J Am Acad Dermatol (2006) 1.42
Biopharmaceuticals and biosimilars in psoriasis: what the dermatologist needs to know. J Am Acad Dermatol (2012) 1.40
Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring. Antimicrob Agents Chemother (2011) 1.38
Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris. J Drugs Dermatol (2007) 1.17
Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials. Health Qual Life Outcomes (2003) 1.17
An intravaginal ring for the simultaneous delivery of multiple drugs. J Pharm Sci (2012) 1.17
Severity of premenstrual symptoms in a health maintenance organization population. Obstet Gynecol (2002) 1.17
Assessing a structured, quantitative health outcomes approach to drug risk-benefit analysis. Health Aff (Millwood) (2007) 1.12
Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques. Antimicrob Agents Chemother (2012) 1.11
Low-pass sequencing for microbial comparative genomics. BMC Genomics (2004) 1.11
Tenofovir and tenofovir disoproxil fumarate pharmacokinetics from intravaginal rings. AIDS (2012) 1.10
Contribution of hypoglycemia to medical care expenditures and short-term disability in employees with diabetes. J Occup Environ Med (2005) 1.08
Microbial biofilms on the surface of intravaginal rings worn in non-human primates. J Med Microbiol (2011) 1.07
Physician-to-physician consultation via electronic mail: the Walter Reed Army Medical Center Ask a Doc system. Mil Med (2002) 1.05
Pharmacokinetics of a multipurpose pod-intravaginal ring simultaneously delivering five drugs in an ovine model. Antimicrob Agents Chemother (2013) 0.97
The cost consequences of treatment-resistant depression. J Clin Psychiatry (2004) 0.97
Deregulated expression in Ph+ human leukemias of AHI-1, a gene activated by insertional mutagenesis in mouse models of leukemia. Blood (2004) 0.96
Impact of efalizumab on psoriasis-specific patient-reported outcomes. Results from three randomized, placebo-controlled clinical trials of moderate to severe plaque psoriasis. J Drugs Dermatol (2004) 0.94
Study protocol: the Back Pain Outcomes using Longitudinal Data (BOLD) registry. BMC Musculoskelet Disord (2012) 0.94
Pharmacokinetics and pharmacodynamics of multiple weekly subcutaneous efalizumab doses in patients with plaque psoriasis. J Clin Pharmacol (2005) 0.94
Clinical symptoms of skin, nails, and joints manifest independently in patients with concomitant psoriasis and psoriatic arthritis. PLoS One (2011) 0.92
Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials. J Am Acad Dermatol (2011) 0.92
Efficacy and Safety of Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam in Patients With Psoriasis Vulgaris - a Randomized Phase III Study (PSO-FAST). J Drugs Dermatol (2015) 0.91
Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma. Toxicol Appl Pharmacol (2013) 0.90
Study protocol- Lumbar Epidural steroid injections for Spinal Stenosis (LESS): a double-blind randomized controlled trial of epidural steroid injections for lumbar spinal stenosis among older adults. BMC Musculoskelet Disord (2012) 0.88
Premenstrual dysphoric disorder: is there an economic burden of illness? Med Care (2002) 0.87
Systematic review of comparative effectiveness data for oncology orphan drugs. Am J Manag Care (2012) 0.86
Construction of a dairy microbial genome catalog opens new perspectives for the metagenomic analysis of dairy fermented products. BMC Genomics (2014) 0.84
Back pain in seniors: the Back pain Outcomes using Longitudinal Data (BOLD) cohort baseline data. BMC Musculoskelet Disord (2014) 0.83
Compulsive cell phone use and history of motor vehicle crash. J Adolesc Health (2013) 0.82
Patterns of initial pharmacotherapy for Parkinson's disease in the United States. J Geriatr Psychiatry Neurol (2006) 0.80
Screening for lung cancer. CMAJ (2014) 0.80
A Markov decision process approach to multi-category patient scheduling in a diagnostic facility. Artif Intell Med (2011) 0.80
Lactobacillus delbrueckii ssp. lactis and ssp. bulgaricus: a chronicle of evolution in action. BMC Genomics (2014) 0.79
Using cost-effectiveness analysis to support research and development portfolio prioritization for product innovations in measles vaccination. J Infect Dis (2011) 0.79
Design and rationale of the HCC BRIDGE study in China: a longitudinal, multicenter cohort trial in hepatocellular carcinoma. BMC Gastroenterol (2011) 0.78
Medicare's national coverage determinations in diagnostic radiology: examining evidence and setting limits. Acad Radiol (2012) 0.77
Symptom control and improved functioning: the effect of omalizumab on asthma-related quality of life (ARQL). J Asthma (2005) 0.76
KHA-CARI guideline: Diagnosis and treatment of urinary tract infection in children. Nephrology (Carlton) (2015) 0.76
Innovation in diagnostic imaging services: assessing the potential for value-based reimbursement. Acad Radiol (2011) 0.76
Identification and visualization of CD8+ T cell mediated IFN-γ signaling in target cells during an antiviral immune response in the brain. PLoS One (2011) 0.76
Rethinking eligibility creep. J Am Acad Dermatol (2008) 0.75
Eruptive papules during efalizumab (anti-CD11a) therapy of psoriasis vulgaris: a case series. BMC Dermatol (2007) 0.75
Induction Therapy, Rejection, and Graft Outcomes in Pediatric and Adolescent Kidney Transplant Recipients. Transplantation (2017) 0.75
The Effect of Tildrakizumab on Cardiometabolic Risk Factors in Psoriasis by Metabolic Syndrome Status: Post Hoc Analysis of Two Phase 3 Trials (ReSURFACE 1 and ReSURFACE 2). J Drugs Dermatol (2020) 0.75
Improving clinical trial design in psoriasis: Perspectives from the global dermatology community. J Dermatolog Treat (2010) 0.75
Long-term uveal and capsular biocompatibility of a new fluid-filled, modular accommodating intraocular lens. J Cataract Refract Surg (2020) 0.75
Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 Trials. J Drugs Dermatol (2016) 0.75
The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethasone Dipropionate Improves the Health-Related Quality of Life in Patients With Psoriasis Vulgaris: Results from the Randomized PSO-FAST Study. J Drugs Dermatol (2016) 0.75
Different treatment outcomes with different formulations of clobetasol propionate 0.05% for the treatment of plaque psoriasis. J Dermatolog Treat (2008) 0.75
One-Year Pharmacovigilance Update of Brodalumab. J Drugs Dermatol (2020) 0.75